BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹55 Cr | ₹54 Cr | ₹53 Cr | ₹63 Cr | ₹35 Cr |
What is the latest Total Current Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹53 Cr |
| Mar2022 | ₹63 Cr |
| Mar2021 | ₹35 Cr |
How is Total Current Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹55 Cr | 0.62 | |
| Mar2024 | ₹54 Cr | 2.00 | |
| Mar2023 | ₹53 Cr | -16.02 | |
| Mar2022 | ₹63 Cr | 82.37 | |
| Mar2021 | ₹35 Cr | - | |
Compare Total Current Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹97.4 Cr | -3.4% | -13.6% | -74.6% | Stock Analytics | |
| ADANI ENTERPRISES | ₹249,145.0 Cr | -1.2% | -13.6% | -6.8% | Stock Analytics | |
| REDINGTON | ₹16,988.0 Cr | -6.5% | -15.9% | 3% | Stock Analytics | |
| HONASA CONSUMER | ₹9,414.6 Cr | 2.9% | -8% | 34.7% | Stock Analytics | |
| MMTC | ₹8,964.0 Cr | 13.5% | -4.9% | 25.2% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹6,910.7 Cr | -4.6% | -20.6% | 32.3% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -3.4% |
-13.6% |
-74.6% |
| SENSEX | -2.4% |
-10.9% |
0.2% |
You may also like the below Video Courses